3Amel-Kashipaz MR, Huggins ML, Lanyon P, Robins A, et al. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8 (-) and CD8 (+) T cells in systemic lupus erythematosus. J Autoimmun, 2001, 17: 155-163.
4Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum,1982, 25: 1271-1277.
5Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35: 630-640.
6Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med, 1994,179: 1109-1118.
7Jonuleit H, Schmitt E, Stassen M, et al. Identification and functional characterization of human CD4 (+) CD25 (+) T cells with regulatory properties isolated from peripheral blood. J Exp Med, 2001, 193:1285-1294.
8Jinquan T, Quan S, Jacobi HH, et al. Cutting edge: expression of the NF of activated T cells in eosinophils: regulation by IL-4 and IL-5.J Immunol, 1999, 163: 21-24.
9Forster R, Schubel A, Breitfeld D, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell, 1999, 99: 23-33.
10Richardson BC.Role of DNA methylation in the regulation of cell function:autoimmunity,aging and cancer.J Nutr,2002,132 (8 Suppl):2401 S-2405S.
